Created in 1998 (Belgium), CALMICLEAN own 2466 sister brands and 17477 competing brands. The CALMICLEAN brand is owned by JOHNSON & JOHNSON, a company listed in New York. The sector of CALMICLEAN is Drug Manufacturers.
Investment simulator :
Portfolio valuation
JOHNSON & JOHNSON
(CALMICLEAN)
over 5 years*
USD 157.28